Pacific Biosciences Of California (PACB) Assets Average (2011 - 2026)

Pacific Biosciences Of California's Assets Average history runs 16 years deep, the most recent figure standing at $783.2 million for Q1 2026.

• In Q1 2026, Assets Average fell 26.15% year-over-year to $783.2 million; the TTM figure through Mar 2026 stood at $783.2 million (down 26.15% YoY), while the FY2025 annual figure was $1.0 billion, down 32.0% from the prior year.
• Assets Average was $783.2 million for Q1 2026 at Pacific Biosciences Of California, down from $793.6 million in the prior quarter.
• In the past five years, Assets Average ranged from a high of $2.0 billion in Q1 2022 to a low of $783.2 million in Q1 2026.
• Historically, Assets Average has averaged $1.5 billion across 5 years, with a median of $1.7 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Assets Average soared 136.59% in 2022, then sank 46.96% in 2025.
• A 5-year view of Assets Average shows it stood at $1.8 billion in 2022, then increased by 1.63% to $1.8 billion in 2023, then retreated by 25.62% to $1.4 billion in 2024, then tumbled by 41.44% to $793.6 million in 2025, then declined by 1.31% to $783.2 million in 2026.
• The last three Assets Average figures came in at $783.2 million (Q1 2026), $793.6 million (Q4 2025), and $814.3 million (Q3 2025), per Business Quant data.